Wave Life Sciences Ltd. — Director's Dealing 2019

Sep 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2019-09-04

Reporting Person: Wagner Heidi L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-04	Share Option (right to buy)	$21.03	A	21000	Acquired	2024-09-04	Ordinary Shares (21000)	Direct

Footnotes

F1: The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 25% of the shares on September 4, 2020 and the remainder vests quarterly thereafter until September 4, 2023.